Maggs JR, Chapman RW (2008) An update on primary sclerosing cholangitis. Curr Opin Gastroenterol 24:377–383
Nair AV, Macdonald DB, Kelly EM, Satheesh S, Venugopalan P, Soman DK (2022) Utility of MRCP in surveillance of primary sclerosing cholangitis associated hepatobiliary malignancy: 15 year experience at a single institution in Ontario, Canada. Clin Imaging 81:47–53
Hercun J, Willems P, Bilodeau M, Vincent C, Alvarez F (2022) Long-term follow-up into adulthood of pediatric-onset primary sclerosing cholangitis and autoimmune sclerosing cholangitis. JPGN Rep 3:e220
Article PubMed PubMed Central Google Scholar
Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, Furuya KN, Gottrand M, Gottrand F, Gupta N, Homan M, Kamath BM, Kim KM, Kolho KL, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, O’Cathain N, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Jensen MK (2017) The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology 66:518–527
Article CAS PubMed Google Scholar
Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G (2001) Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33:544–553
Article CAS PubMed Google Scholar
Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL (2013) Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology 58:1392–1400
Grigoriadis A, Morsbach F, Voulgarakis N, Said K, Bergquist A, Kartalis N (2020) Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis. Scand J Gastroenterol 55:228–235
Article CAS PubMed Google Scholar
Patil K, Ricciuto A, Alsharief A, Al-Rayahi J, Amirabadi A, Church PC, Kamath BM, Greer MC (2020) Magnetic resonance cholangiopancreatography severity predicts disease outcomes in pediatric primary sclerosing cholangitis: a reliability and validity study. Hepatol Commun 4:208–218
Article CAS PubMed Google Scholar
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
Article CAS PubMed Google Scholar
Hallgren KA (2012) Computing inter-rater reliability for observational data: an overview and tutorial. Tutor Quant Methods Psychol 8:23–34
Article PubMed PubMed Central Google Scholar
Grave EC, Loehfelm T, Corwin MT, Zepeda J, Bath HK, Dhaliwal S, Yazdanfar M, Bowlus CL (2024) Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitis. Abdom Radiol (NY) 49:60–68
Majoie CB, Reeders JW, Sanders JB, Huibregtse K, Jansen PL (1991) Primary sclerosing cholangitis: a modified classification of cholangiographic findings. AJR Am J Roentgenol 157:495–497
Article CAS PubMed Google Scholar
Grigoriadis A, Ringe KI, Andersson M, Kartalis N, Bergquist A (2021) Assessment of prognostic value and interreader agreement of ANALI scores in patients with primary sclerosing cholangitis. Eur J Radiol 142:109884
Ferrara C, Valeri G, Salvolini L, Giovagnoni A (2002) Magnetic resonance cholangiopancreatography in primary sclerosing cholangitis in children. Pediatr Radiol 32:413–417
McCrary J, Trout AT, Mahalingam N, Singh R, Rojas CC, Miethke AG, Dillman JR (2022) Associations between quantitative MRI metrics and clinical risk scores in children and young adults with autoimmune liver disease. AJR Am J Roentgenol 219:142–150
Gilligan LA, Trout AT, Lam S, Singh R, Tkach JA, Serai SD, Miethke AG, Dillman JR (2020) Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography. Abdom Radiol (NY) 45:168–176
Vuppalanchi R, Are V, Telford A, Young L, Mouchti S, Ferreira C, Kettler C, Gromski M, Akisik F, Chalasani N (2023) A composite score using quantitative magnetic resonance cholangiopancreatography predicts clinical outcomes in primary sclerosing cholangitis. JHEP Rep 5:100834
Article PubMed PubMed Central Google Scholar
Cazzagon N, El Mouhadi S, Vanderbecq Q, Ferreira C, Finnegan S, Lemoinne S, Corpechot C, Chazouillères O, Arrivé L (2022) Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis. JHEP Rep 4:100577
Article PubMed PubMed Central Google Scholar
Ismail MF, Hirschfield GM, Hansen B, Tafur M, Elbanna KY, Goldfinger MH, Ridgway GR, Jhaveri KS (2022) Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores. Eur Radiol 32:67–77
留言 (0)